companydata.dkBiomedica-Anpartsselskab: Financial statements 2023
CVR: 15234474
Biomedica-Anpartsselskab (CVR 15234474) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 754,666 and a net result of DKK 588,686 compared with DKK 497,881 the year before. That is an increase of 17.8% compared with the year before. Equity amounted to DKK 2,423,133. The solvency ratio was 95.2%.
- Gross Profit
- 754,666 kr.
- Profit/Loss
- 588,686 kr.
- Equity
- 2,423,133 kr.
- Total Assets
- 2,544,271 kr.
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 755 t. | 589 t. | 2.4 mio. | 0 |
| 2022 | - | 640 t. | 498 t. | 1.8 mio. | - |
| 2021 | - | 512 t. | 402 t. | 1.3 mio. | - |
| 2020 | 2 mio. | 1.1 mio. | 828 t. | 916 t. | - |
| 2019 | 2.7 mio. | 1.7 mio. | 1.4 mio. | 107 t. | - |
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Biomedica-Anpartsselskab has published its annual report for 2022. Gross profit came to DKK 640,481, and the net result was DKK 497,881.
About Biomedica-Anpartsselskab
Biomedica-Anpartsselskab is a Danish company of the type Anpartsselskab based in Frederiksberg C, founded in 1991. The company is registered under the industry Vikarbureauers aktiviteter og anden personaleformidling. The management consists of Lars Anders Baumbach. The company is owned by Lars Anders Baumbach. In 2025, the company reported a gross profit of DKK 0 and a net result of DKK -28,050 compared with DKK 307,277 the year before. Equity amounted to DKK 2,702,360.